Evidence map›Paper›PMID 37015970›Full record

ArticleBone marrow transplantation2023

The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia.

Fiona Fernando, Andrew J Innes, Simone Claudiani, Angharad Pryce, Chloe Hayden, Jenny Byrne, Paolo Gallipoli, Mhairi Copland, Jane F Apperley, Dragana Milojkovic

Open access · greenAbstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Fiona FernandoCentre for Haematology, Imperial College London, London, UK. f.fernando@nhs.net.
Andrew J InnesCentre for Haematology, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-0918-8882
Simone ClaudianiCentre for Haematology, Imperial College London, London, UK.
Angharad PryceCentre for Haematology, Imperial College London, London, UK.
Chloe HaydenNorth West London Pathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
Jenny ByrneCentre for Clinical Haematology, Nottingham University Hospital NHS Trust, Nottingham, UK.
Paolo GallipoliCentre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Mhairi CoplandPaul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jane F ApperleyCentre for Haematology, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-1710-1794
Dragana MilojkovicCentre for Haematology, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust · GBBlood Cancer UK · GBNottingham University Hospitals NHS Trust · GBQueen Mary University of London · GB

Funding

Cancer Research UK 27964Department of HealthMedical Research Council G1000288
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidHumansNiacinamideProtein Kinase InhibitorsPyrazolesasciminibNiacinamideProtein Kinase InhibitorsPyrazoles

Identifiers

PMID37015970
OpenAlexW4362555331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.